Home / Health / 5 new things we learned about COVID-19 in April 2021

5 new things we learned about COVID-19 in April 2021

The amount of information about the coronavirus is dizzying. It is difficult to keep track of what myths are known and what advice we should follow. That’s why we’ve rounded up the five most important new things we learned about COVID-19 in April:

1.The blood clot was linked to the Johnson & Johnson vaccine – but it was Extremely Hard to find.

The single-injectable Johnson & Johnson vaccine hit a number of headlines in April when the Centers for Disease Control and Prevention and the Food and Drug Administration called for a temporary halt of vaccination.

The group states that “with great care” they are considering a number of events that some recipients have. (Most all women under 50) developed a rare disorder involving blood clots and low blood platelets within two weeks after. Get their shot

The CDC and FDA have now reported 1

5 women who experienced extremely rare results within two weeks of their vaccination. That means it’s a visible outcome of 1.9 people for every million people who get fired.

Given the difficulty of the patient and the risks that COVID-19 still poses – groups have re-approved the vaccine, although warnings are now made about very rare outcomes.

“The benefits of the vaccine still outweigh these risks and we now have detailed information on the label warning them of these risks,” said EMA Executive Director Emer Cooke. “We are confident it can be used properly.”

2. There may be a link between vaccinations and changes in the menstrual cycle.

In April, many anecdotes began to roll out on Twitter and in the news about women who had changed in connection with the post-vaccination period. More specifically, some women report that they are having increased blood flow and late menstrual cycles.

Health professionals do not have much concrete information. (Or is there really) about the possible vaccination / menstrual link right now, in part because period-related symptoms were not monitored during clinical trials. But the timing can be extremely challenging to study.

“Menstruation is a complex process that can be influenced by factors such as environmental changes, stress, sleep and certain medications,” said Dr. Daniel Jones, board-certified obstetrician-gynecologist in the Texas Tech Center. Lexus told HuffPost.

Ultimately, though, the potential changes are more of a priority for women’s health professionals, and women themselves may want to recognize. But there is really no real concern that these could be sustained and catastrophic changes.

In general, women who have had heavier menstrual cycles after getting the COVID-19 vaccine should generally follow the general advice when battling heavy periods, such as taking over-the-counter anti-inflammatory drugs or applying heat.

In addition, people who have had severe symptoms following vaccination should be reported through the Vaccine Adverse Event Reporting System (VAERS).

3.Pregnant women may be at greater risk of developing serious COVID-19 than previously thought.

COVID-19 may pose a greater risk to pregnant women and babies than previously understood, a study in April warned.

“Women with COVID-19 during pregnancy were 50% more likely to have pregnancy complications (such as premature birth, preeclampsia, intensive care, and death) compared to women who were infected with COVID-19 during pregnancy. With pregnant women unaffected by COVID-19, ”said Dr. Aris Papage dressing, Professor of Fetal Medicine at Oxford University in England.

Newborns born to mothers infected with COVID-19 are almost three times more likely to develop serious medical complications, most of which are due to premature birth.

However, these increased risks appear to be concentrated in women with COVID-19 who have the condition.

“However, the good news is that the risks are similar in women with asymptomatic and non-infected women.

And experts stress the COVID-19 vaccine is safe and effective for pregnant women.

4. The younger the child is less likely to transmit the virus.

Unfortunately, much of the conversations about children and COVID-19 that take place at the policy level and on social media lack little difference, especially when it comes to the risks that children pose. another

New research published in April looking at data from Israel, which schools opened and closed several times during the outbreak, further clarified the question of whether children are involved in the spread of the coronavirus in communities. They found that younger students (up to 9 years of age) had very low transmission rates.

“Our results suggest that children aged 0 to 9 do not have a SARS-CoV-2 infection rate during the time of enrollment, and it may be assumed that they do not play a role in the COVID-19 epidemic. During this period, ”the researchers wrote.

However, they cannot confirm that the same is true for adolescents and suggest: “Returning to a school for youth aged 10 to 19 is safer only if the epidemic is under control and after. Steps are being taken to reduce the spread in schools. ”

5. The COVID-19 vaccine does not increase the risk of facial paralysis.

In a preliminary clinical trial for Pfizer and Modernna vaccines, a number of participants developed Bell’s palsy, a condition that causes sudden weakness on the half of the face that often responds. Against viral infections

As a result, the FDA has monitored those who received those vaccines for possible paralysis since last winter, while emphasizing all the time that Bell’s palsy was not considered a side effect of the vaccine.

New research, published in April, supports the claims, finding no signs that the COVID-19 vaccine should increase the risk of facial paralysis or related events. Researchers analyzed more than 133,000 vaccine adverse reactions reported to the World Health Organization and found that less than 1% were associated with facial paralysis.

They noted that this was in line with the same reports associated with other viral vaccines as those who received influenza vaccination.

“Risk,” the researchers wrote in JAMA Internal Medicine, “likely to be very low, as with other viral vaccines.”

Experts are still learning about COVID-19, information on the matter is known or available in publications. But the hints can change as scientists discover more about the virus. Please check the Centers for Disease Control and Prevention for the latest advice.

Source link